Launched in 2024, Trace Neuroscience is a biopharmaceutical company on a mission to expand the promise of genomic medicine for people living with neurodegenerative diseases. With an initial focus on ALS, the company is developing novel therapies to restore UNC13A protein function to re-establish healthy communication between nerves and muscle cells.
Company Details
- Employees
- 19
- Founded
- -
- Address
- 750 Gateway Blvd,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.traceneuro.com
- HQ
- South San Francisco, California
Trace Neuroscience Questions
Trace Neuroscience's website is http://www.traceneuro.com
Trace Neuroscience's LinkedIn profile is https://www.linkedin.com/company/traceneuroscience
Trace Neuroscience has
19 employees.
View email and phone details for 19
employees at Trace Neuroscience.
Trace Neuroscience's industry is
Biotechnology Research
Trace Neuroscience's top competitors are
Avenue Biosciences,
Curve Biosciences,
Metsera,
Bluejay Therapeutics,
Nuvig Therapeutics Inc.,
Marea Therapeutics,
Tenvie Therapeutics,
Arda Therapeutics,
Signios Biosciences,
Siteone Therapeutics, Inc..
Trace Neuroscience's categories are Biotechnology Research
Trace Neuroscience's founding year is 2024
